Logo for Pharmadrug Inc.
PHRX
+50.00%

Pharmadrug Inc.

Statut
ActifT2
Émis et en Circulation104,556,647
Réservé pour Émission15,240,323
DeviseCAD
CSE IndiceNo

Citation

Dernier Prix0.0150.005 (50.00%)
Volume217,430
Changement0.005
Taille de l'offre28,000
Prix de l'offre0.015
Prix de la demande0.02
Taille de la demande770,000
Clôture précédente0.01
Ouverture0.015
Haut du jour0.015
Bas du jour0.015
Haut de 52 semaines0.075
Bas de 52 semaines0.005

Pharmadrug Inc.

Graphiques par TradingView

Affichage de la profondeur

Transactions Récentes

À propos

Pharmadrug Inc.

Date d'inscription
16 août 2018

PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs. PharmaDrug owns 100% of Pharmadrug Production GmbH (“Pharmadrug Production”), a German medical cannabis distributor, with a Schedule I European Union narcotics license and German EuGMP certification allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the European Union. PharmaDrug owns 100% Sairiyo Therapeutics (“Sairiyo”), a biotech company that specializes in researching and reformulating established natural medicines with a goal of bringing them through clinical trials and the associated regulatory approval process in the US and Europe. Sairiyo is currently developing its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious disease and rare cancers. Sairiyo is also conducting R&D in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also owns 100% of Super Smart, a company building a vertically integrated retail business with the goal to elevate the use of functional mushrooms as natural based medicines.